USP tracks drug quality across world regions; FDA simplifies drug recall searches;

> The US Pharmacopeial Convention's Promoting the Quality of Medicines program has launched a database of medicines analyzed in various world regions prone to counterfeits and substandard drugs. Story

> The FDA now boasts a more consumer-friendly recall search engine that presents results in table format. Announcement | Recall Search Tool

> Methylphenidate HCl, a generic form of Ritalin, has been added to the FDA's drug shortages list; both Sandoz and Covidien report API constraints. List

> The FDA appears to be focusing on third-part inspections of foreign drug-making plants but ramping up for FDA agent inspections of medical device facilities. Article

> Germany's Glycotope Biotechnology is adding cleanroom facilities as a first step in expanding GMP-production capacity. Glycotype release

> The PharmaLine PQ UV disinfection system provides chemical-free disinfection for low-flow pharma and biotech applications. Release

> AAIPharma has built and moved into a purpose-built compendial raw materials testing area in its Wilmington, NC, headquarters. AAIPharma announcement

> Daiichi Sankyo has launched Kitasato Daiichi Sankyo Vaccine Co. to manufacture and market biological drug products. Daiichi release

> New GMP rules in China are likely to drive consolidation among the country's 5,000-plus drugmakers. Story

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.